Suzanne Carreira

12PUBLICATIONS
105CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Jan 09, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

|Feb 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.

Antje Neeb, Ines Figueiredo, Denisa Bogdan

|Oct 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.

Christina Guo, Adam Sharp, Bora Gurel

|Jun 24, 2023
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer.

Eliot B Blatt, Karla Parra, Antje Neeb

|Jun 18, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors.

Dionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal

Pageof 2